Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 16231029)

Published in Int J Obes (Lond) on February 01, 2006

Authors

L Kennedy1, D C Bittel, N Kibiryeva, S P Kalra, R Torto, M G Butler

Author Affiliations

1: Department of Medicine, Division of Endocrinology, University of Florida, Gainesville, FL, USA.

Articles citing this

Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity. Int J Obes (Lond) (2011) 1.07

Mood, food, and obesity. Front Psychol (2014) 1.07

Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. Clin Endocrinol (Oxf) (2007) 1.02

Impaired hypothalamic regulation of endocrine function and delayed counterregulatory response to hypoglycemia in Magel2-null mice. Endocrinology (2011) 1.00

Strength characterization of knee flexor and extensor muscles in Prader-Willi and obese patients. BMC Musculoskelet Disord (2009) 0.99

The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab (2010) 0.93

A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome. J Hum Nutr Diet (2012) 0.90

Leptin levels among prepubertal children with Down syndrome compared with their siblings. J Pediatr (2007) 0.87

Deep Brain Stimulation for Obesity. Cureus (2015) 0.79

Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment. Int J Obes (Lond) (2014) 0.77

Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study. J Pediatr Endocrinol Metab (2014) 0.76

Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: a randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab (2017) 0.75

Articles by these authors

Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics (1993) 4.86

Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature (1989) 4.72

Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology (1984) 2.89

Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet (1986) 2.66

Multiplex PCR of three dinucleotide repeats in the Prader-Willi/Angelman critical region (15q11-q13): molecular diagnosis and mechanism of uniparental disomy. Hum Mol Genet (1993) 2.02

Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet (1999) 1.93

Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet (1983) 1.82

The frequency of uniparental disomy in Prader-Willi syndrome. Implications for molecular diagnosis. N Engl J Med (1992) 1.78

Obese children show hyperactivation to food pictures in brain networks linked to motivation, reward and cognitive control. Int J Obes (Lond) (2010) 1.75

Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res (1997) 1.75

Breakage in the SNRPN locus in a balanced 46,XY,t(15;19) Prader-Willi syndrome patient. Hum Mol Genet (1996) 1.70

Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet (1993) 1.68

Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med (1995) 1.60

Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet (2006) 1.54

Zinc and cadmium can promote rapid nuclear translocation of metal response element-binding transcription factor-1. J Biol Chem (2000) 1.53

An unusual case of phaeochromocytoma. J Assoc Physicians India (1987) 1.40

Molecular cytogenetics of Prader-Willi and Angelman syndromes. Lancet (1991) 1.40

Trisomy 18 mosaicism in a 24-year-old white woman with normal intelligence and skeletal abnormalities. Am J Med Genet (1994) 1.39

Prenatal diagnosis and carrier detection of a cryptic translocation by using DNA markers from the short arm of chromosome 5. Am J Hum Genet (1989) 1.34

New marker of B lymphocytes, MB2: comparison with other lymphocyte subset markers active in conventionally processed tissue sections. J Clin Pathol (1987) 1.30

Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology (1985) 1.28

Comparison of X-chromosome inactivation patterns in multiple tissues from human females. J Med Genet (2007) 1.25

Do some patients with Seckel syndrome have hematological problems and/or chromosome breakage? Am J Med Genet (1987) 1.23

An infant with deletion of the distal long arm of chromosome 15 (q26.1----qter) and loss of insulin-like growth factor 1 receptor gene. Am J Med Genet (1991) 1.23

Rapid technique of DNA-DNA in situ hybridisation on formalin fixed tissue sections using microwave irradiation. J Clin Pathol (1987) 1.17

Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res (1999) 1.17

Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides (1988) 1.17

Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele. Am J Med Genet (1997) 1.15

Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res (2000) 1.12

Pancytopenia--a six year study. J Assoc Physicians India (2001) 1.12

Meniscal ossicle: radiographic and MR imaging findings. Radiology (1995) 1.12

Neuropeptide-Y innervation of beta-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis. Endocrinology (1992) 1.11

Intercontinental karyotypic differentiation of Chironomus entis Shobanov, a Holarctic member of the C. plumosus group (Diptera, Chironomidae). Genome (2000) 1.09

Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regul Pept (2001) 1.08

A 26-month-old child with Marden-Walker syndrome and pyloric stenosis. Am J Med Genet (1987) 1.07

Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity. Int J Obes (Lond) (2011) 1.07

Metacarpophalangeal pattern profile analysis in Prader-Willi syndrome. Clin Genet (1982) 1.07

Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner. Regul Pept (1998) 1.06

Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. Int J Obes (Lond) (2008) 1.05

Brief report: non-random X chromosome inactivation in females with autism. J Autism Dev Disord (2005) 1.04

Microarray analysis of gene/transcript expression in Prader-Willi syndrome: deletion versus UPD. J Med Genet (2003) 1.04

No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD). J Med Genet (2002) 1.04

Distinct 15q genotypes in Russell-Silver and ring 15 syndromes. Am J Med Genet (1996) 1.04

The relationship between compulsive behaviour and academic achievement across the three genetic subtypes of Prader-Willi syndrome. J Intellect Disabil Res (2007) 1.03

Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogenet Genome Res (2009) 1.03

Body mass influences cortical bone mass independent of leptin signaling. Bone (2008) 1.03

Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations. Am J Ment Retard (1999) 1.02

Neural regulation of luteinizing hormone secretion in the rat. Endocr Rev (1983) 1.02

Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol Ther (2001) 1.01

Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis. Endocrinology (1999) 1.00

Leptin receptor immunoreactivity is associated with the Golgi apparatus of hypothalamic neurons and glial cells. J Neuroendocrinol (1998) 0.99

Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin. Endocrinology (1998) 0.99

Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY. Regul Pept (1987) 0.99

Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling. Biochem Biophys Res Commun (2000) 0.99

Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus. Endocrinology (1994) 0.98

Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. 1985. Obes Res (1997) 0.97

A new method of hydrolysis for the identification of acid glycoprotein. Med Lab Technol (1973) 0.97

Adenovirus keratitis: a role for interleukin-8. Invest Ophthalmol Vis Sci (2000) 0.96

An anthropometric study of 38 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet (1987) 0.96

Effects of hypothalamic and preoptic electrochemical stimulation on gonadotropin and prolactin release in proestrous rats. Endocrinology (1971) 0.96

Non-typhi salmonella in children with severe malaria. East Afr Med J (2002) 0.96

Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. Endocrinology (1999) 0.95

Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior. Brain Res (1988) 0.95

Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology (2002) 0.95

Hyperleptinemia depletes fat from denervated fat tissue. Biochem Biophys Res Commun (1999) 0.95

Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tract. Regul Pept (1983) 0.95

Localization of neuropeptide-Y immunoreactivity in estradiol-concentrating cells in the hypothalamus. Endocrinology (1990) 0.94

Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology (1990) 0.94

Telomere reduction in giant cell tumor of bone and with aging. Cancer Genet Cytogenet (1993) 0.94

Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res (1995) 0.94

Acetone/periodate-lysine-paraformaldehyde (PLP) fixation and improved morphology of cryostat sections for immunohistochemistry. Histopathology (1987) 0.94

Robinow syndrome: report of two patients and review of literature. Clin Genet (1987) 0.93

Paternal hydrocarbon exposure in Prader-Willi syndrome. Lancet (1987) 0.93

Norepinephrine-like effects of neuropeptide Y on LH release in the rat. Life Sci (1984) 0.93

Increased frequency of sister-chromatid exchanges in alcoholics. Mutat Res (1981) 0.92

The extracellular matrix of reparative tissue in the vitreous: fibronectin production in proliferative diabetic retinopathy membranes. Eye (Lond) (1993) 0.92

Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action. Endocrinology (1992) 0.91

Prader-Willi syndrome and a deletion/duplication within the 15q11-q13 region. J Med Genet (2002) 0.91

Role of leptin in orexigenic neuropeptide expression during lactation in rats. J Neuroendocrinol (2004) 0.90

Neuropeptide Y counteracts the anorectic and weight reducing effects of ciliary neurotropic factor. J Neuroendocrinol (2000) 0.90

Plasma cytokine levels in children with autistic disorder and unrelated siblings. Int J Dev Neurosci (2011) 0.90

Effects of neuropeptide Y, NPY analog (norleucine4-NPY), galanin and neuropeptide K on LH release in ovariectomized (ovx) and ovx estrogen, progesterone-treated rats. Peptides (1988) 0.90

Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats. Endocrinology (1990) 0.90

Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change. Regul Pept (2000) 0.90

Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi syndrome. Ment Retard Dev Disabil Res Rev (2000) 0.90

Global DNA promoter methylation in frontal cortex of alcoholics and controls. Gene (2012) 0.89

Methylation PCR analysis of Prader-Willi syndrome, Angelman syndrome, and control subjects. Am J Med Genet (1998) 0.89

Leptin receptors in estrogen receptor-containing neurons of the female rat hypothalamus. Brain Res (1998) 0.89

Effects of tachykinins on luteinizing hormone release in female rats: potent inhibitory action of neuropeptide K. Endocrinology (1992) 0.89

Resumption with clonidine of pulsatile LH release following acute norepinephrine depletion in ovariectomized rats. Neuroendocrinology (1982) 0.88